WO2006038980A3 - Non-absorbent and absorbent articles for inhibiting the production of exoproteins - Google Patents

Non-absorbent and absorbent articles for inhibiting the production of exoproteins Download PDF

Info

Publication number
WO2006038980A3
WO2006038980A3 PCT/US2005/028366 US2005028366W WO2006038980A3 WO 2006038980 A3 WO2006038980 A3 WO 2006038980A3 US 2005028366 W US2005028366 W US 2005028366W WO 2006038980 A3 WO2006038980 A3 WO 2006038980A3
Authority
WO
WIPO (PCT)
Prior art keywords
absorbent
substituted
amino acid
group
exoproteins
Prior art date
Application number
PCT/US2005/028366
Other languages
French (fr)
Other versions
WO2006038980A2 (en
Inventor
Rae Ellen Syverson
Kristin A Goerg-Wood
Daniel J Devine
Original Assignee
Kimberly Clark Co
Rae Ellen Syverson
Kristin A Goerg-Wood
Daniel J Devine
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US10/955,858 external-priority patent/US20060067991A1/en
Priority claimed from US10/955,821 external-priority patent/US20060067990A1/en
Application filed by Kimberly Clark Co, Rae Ellen Syverson, Kristin A Goerg-Wood, Daniel J Devine filed Critical Kimberly Clark Co
Priority to BRPI0515949-0A priority Critical patent/BRPI0515949A/en
Priority to EP05785615A priority patent/EP1793871A2/en
Priority to AU2005292655A priority patent/AU2005292655A1/en
Priority to JP2007534582A priority patent/JP2008514698A/en
Publication of WO2006038980A2 publication Critical patent/WO2006038980A2/en
Publication of WO2006038980A3 publication Critical patent/WO2006038980A3/en
Priority to IL181198A priority patent/IL181198A0/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/42—Use of materials characterised by their function or physical properties
    • A61L15/46—Deodorants or malodour counteractants, e.g. to inhibit the formation of ammonia or bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/20—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing organic materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/20—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
    • A61L2300/21—Acids
    • A61L2300/214—Amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/432—Inhibitors, antagonists
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/60—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a special physical form
    • A61L2300/602—Type of release, e.g. controlled, sustained, slow
    • A61L2300/604—Biodegradation

Abstract

Non-absorbent and absorbent articles for inhibiting the production of exoproteins from Gram positive bacteria are disclosed. The non-absorbent and absorbent articles include an effective amount of a precursor compound having the general formula (I): wherein R1 is selected from the group consisting of formula (II) and formula (III); R7 is -OCH2-; X is 0 or 1; R5 is a substituted or unsubstituted aromatic ring or a monovalent saturated or unsaturated, substituted or unsubstituted, branched or straight chain hydrocarbyl moiety that may or may not be substituted with hetero atoms; R6 is selected from the group consisting of an amino acid, a methyl ester of an amino acid, and an ethyl ester of an amino acid; R2, R3, and R4 are independently selected from the group consisting of H, OH, COOH.
PCT/US2005/028366 2004-09-30 2005-08-10 Non-absorbent and absorbent articles for inhibiting the production of exoproteins WO2006038980A2 (en)

Priority Applications (5)

Application Number Priority Date Filing Date Title
BRPI0515949-0A BRPI0515949A (en) 2004-09-30 2005-08-10 non-absorbent and absorbent articles for inhibiting exoprotein production
EP05785615A EP1793871A2 (en) 2004-09-30 2005-08-10 Non-absorbent and absorbent articles for inhibiting the production of exoproteins
AU2005292655A AU2005292655A1 (en) 2004-09-30 2005-08-10 Non-absorbent and absorbent articles for inhibiting the production of exoproteins
JP2007534582A JP2008514698A (en) 2004-09-30 2005-08-10 Non-absorbable article and absorbent article for inhibiting production of foreign protein
IL181198A IL181198A0 (en) 2004-09-30 2007-02-07 Non-absorbent and absorbent articles for inhibiting the production of exoproteins

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US10/955,858 2004-09-30
US10/955,858 US20060067991A1 (en) 2004-09-30 2004-09-30 Non-absorbent articles for inhibiting the production of exoproteins
US10/955,821 2004-09-30
US10/955,821 US20060067990A1 (en) 2004-09-30 2004-09-30 Absorbent articles for inhibiting the production of exoproteins

Publications (2)

Publication Number Publication Date
WO2006038980A2 WO2006038980A2 (en) 2006-04-13
WO2006038980A3 true WO2006038980A3 (en) 2006-06-29

Family

ID=36066376

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2005/028366 WO2006038980A2 (en) 2004-09-30 2005-08-10 Non-absorbent and absorbent articles for inhibiting the production of exoproteins

Country Status (8)

Country Link
EP (1) EP1793871A2 (en)
JP (1) JP2008514698A (en)
KR (1) KR20070057884A (en)
AU (1) AU2005292655A1 (en)
BR (1) BRPI0515949A (en)
IL (1) IL181198A0 (en)
RU (1) RU2007111692A (en)
WO (1) WO2006038980A2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20100130907A1 (en) * 2008-11-21 2010-05-27 Linkel Stephan M Article of manufacture used in contact with human body surfaces

Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB745607A (en) * 1952-12-09 1956-02-29 Geigy Ag J R Improvements relating to antiseptic, bactericidal, or the like agents for disinfection
GB830139A (en) * 1954-12-29 1960-03-09 George Van Norden Morin Fabrics containing bactericidal agents
US3027301A (en) * 1959-03-16 1962-03-27 Us Vitamin Pharm Corp Therapeutic wound healing composition of hydroxypropylamides of hydroxybenzoic acids
US4431427A (en) * 1981-10-05 1984-02-14 University Of Delaware Tampons and their manufacture
US4725590A (en) * 1983-08-24 1988-02-16 Lever Brothers Company Method of relieving pain and inflammatory conditions employing substituted salicylamides
US6245786B1 (en) * 1995-11-22 2001-06-12 Allergan Sales, Inc. Substituted aryl or heteroarylamides having retinoid-like biological activity
US20030165559A1 (en) * 2001-11-21 2003-09-04 Kimberly-Clark Worldwide, Inc. Non-absorbent articles containing additives
US6676957B1 (en) * 2000-11-28 2004-01-13 Kimberly-Clark Worldwide, Inc. Non-absorbent substrates for the inhibition of exoprotein production from gram positive bacteria

Patent Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB745607A (en) * 1952-12-09 1956-02-29 Geigy Ag J R Improvements relating to antiseptic, bactericidal, or the like agents for disinfection
GB830139A (en) * 1954-12-29 1960-03-09 George Van Norden Morin Fabrics containing bactericidal agents
US3027301A (en) * 1959-03-16 1962-03-27 Us Vitamin Pharm Corp Therapeutic wound healing composition of hydroxypropylamides of hydroxybenzoic acids
US4431427A (en) * 1981-10-05 1984-02-14 University Of Delaware Tampons and their manufacture
US4725590A (en) * 1983-08-24 1988-02-16 Lever Brothers Company Method of relieving pain and inflammatory conditions employing substituted salicylamides
US6245786B1 (en) * 1995-11-22 2001-06-12 Allergan Sales, Inc. Substituted aryl or heteroarylamides having retinoid-like biological activity
US6676957B1 (en) * 2000-11-28 2004-01-13 Kimberly-Clark Worldwide, Inc. Non-absorbent substrates for the inhibition of exoprotein production from gram positive bacteria
US20030165559A1 (en) * 2001-11-21 2003-09-04 Kimberly-Clark Worldwide, Inc. Non-absorbent articles containing additives

Also Published As

Publication number Publication date
JP2008514698A (en) 2008-05-08
RU2007111692A (en) 2008-11-10
AU2005292655A1 (en) 2006-04-13
BRPI0515949A (en) 2008-08-12
EP1793871A2 (en) 2007-06-13
KR20070057884A (en) 2007-06-07
WO2006038980A2 (en) 2006-04-13
IL181198A0 (en) 2007-07-04

Similar Documents

Publication Publication Date Title
WO2002100833A1 (en) Rho KINASE INHIBITORS
WO2005089256A3 (en) Antiangiogenic agents
AU2003222450A1 (en) Stabilized ascorbic acid derivatives
WO2008114819A1 (en) Novel adenine compound
HK1055974A1 (en) 9.Alpha.-chloro-6.alpha.-fuoro-17.alpha.-hydroxy-16-methyl-16-beta-methoxycarbonyl-androst-1,4-dienes esterified in position 17.alpha.by a cyclic acylgroup.
UA89672C2 (en) Sulfonylamino(thio)carbonyl compounds
WO2009047298A3 (en) Dimers of harmol or of its derivatives and uses thereof
MXPA02012875A (en) Benzoylpyridine derivative or its salt, fungicide containing it as an active ingredient, its production process and intermediate for producing it.
GB0403864D0 (en) Modulator
WO2007135466A3 (en) Substituted n-acyl homoserine lactones
CA2306963A1 (en) Novel 3,6-hemiketals from the class of 9a-azalides
AU7868400A (en) Neutral-cationic lipid for nucleic acid and drug delivery
AU7259701A (en) Coumarin derivatives with comt inhibiting activity
WO2006038980A3 (en) Non-absorbent and absorbent articles for inhibiting the production of exoproteins
BG107050A (en) Method for the preparation of citalopram
WO2003061652A8 (en) 3-(imidazolyl)-2-alkoxypropanoic acids as tafia inhibitors
WO2002059089A3 (en) Process for the preparation of heterocyclic indene analogs
WO2002002098A3 (en) Antibacterial method and composition with phenolic compounds
CA2309485A1 (en) New 4-arylpiperidine derivatives for the treatment of pruritus
MXPA04002474A (en) Inhibition of exoprotein production using aromatic compositions.
CO5080739A1 (en) ANTIBACTERIAL COMPOUNDS OF CEPHALOSPORINS OF 7-ACILAMINO- 3- (AMINO-CYCLIC GUANIDINE) METHYLENE USEFUL AS PHARMACEUTICAL PRODUCTS AND PROCESSES FOR THEIR PRODUCTION
WO2002050081A3 (en) Antimicrobial agents
WO2001052824A3 (en) Use of particular compounds for prophylaxis and treatment of hepatitis c
AU4926500A (en) Use of nitrogen-free compounds as adhesion promoters for silicon-based scratch-resistant coatings on polycarbonate
WO2009019143A3 (en) Quaternary ammonia groups comprising organosilicon compound and the production thereof

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KM KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NG NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SM SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): BW GH GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LT LU LV MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

WWE Wipo information: entry into national phase

Ref document number: 181198

Country of ref document: IL

WWE Wipo information: entry into national phase

Ref document number: 2005292655

Country of ref document: AU

ENP Entry into the national phase

Ref document number: 2005292655

Country of ref document: AU

Date of ref document: 20050810

Kind code of ref document: A

WWP Wipo information: published in national office

Ref document number: 2005292655

Country of ref document: AU

WWE Wipo information: entry into national phase

Ref document number: 200580032433.4

Country of ref document: CN

WWE Wipo information: entry into national phase

Ref document number: MX/a/2007/003706

Country of ref document: MX

Ref document number: 2007534582

Country of ref document: JP

WWE Wipo information: entry into national phase

Ref document number: 1020077007186

Country of ref document: KR

Ref document number: 1313/CHENP/2007

Country of ref document: IN

WWE Wipo information: entry into national phase

Ref document number: 2005785615

Country of ref document: EP

NENP Non-entry into the national phase

Ref country code: DE

WWE Wipo information: entry into national phase

Ref document number: 2007111692

Country of ref document: RU

WWP Wipo information: published in national office

Ref document number: 2005785615

Country of ref document: EP

ENP Entry into the national phase

Ref document number: PI0515949

Country of ref document: BR